KR960004022B1 - Method of extraction and purification of flavonoid compounds in ginko leaves - Google Patents

Method of extraction and purification of flavonoid compounds in ginko leaves Download PDF

Info

Publication number
KR960004022B1
KR960004022B1 KR1019920017343A KR920017343A KR960004022B1 KR 960004022 B1 KR960004022 B1 KR 960004022B1 KR 1019920017343 A KR1019920017343 A KR 1019920017343A KR 920017343 A KR920017343 A KR 920017343A KR 960004022 B1 KR960004022 B1 KR 960004022B1
Authority
KR
South Korea
Prior art keywords
dioxane
organic solvent
water
extracted
extracting
Prior art date
Application number
KR1019920017343A
Other languages
Korean (ko)
Other versions
KR940006596A (en
Inventor
이재성
김택제
Original Assignee
1996년03월25일
김은영
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 1996년03월25일, 김은영 filed Critical 1996년03월25일
Priority to KR1019920017343A priority Critical patent/KR960004022B1/en
Publication of KR940006596A publication Critical patent/KR940006596A/en
Application granted granted Critical
Publication of KR960004022B1 publication Critical patent/KR960004022B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones

Abstract

The method for extracting and purifying a flavonoid cpd. from gingko leaves comprises (a) extracting and filtering the gingko leaves with an aqueous dioxane solution of pH 8-13 selected from dioxane/water, dioxane/lower alcohol/water and dioxane/lower ketone/water at 30˜55deg. C, (b) extracting the filtered aqueous solution layer with a water-insoluble organic solvent, and extracting and distributing the layer with an organic solvent i.e. butyl alcohol, amyl alcohol, methyl ethyl ketone or ethylacetate, (c) drying the organic solvent layer at 600mmHg or less, and (d) extracting it with an ethyl ether or a petroleum ether. The flavonoid cpd. is useful as a circulatory drug.

Description

은행잎에서 플라보노이드 화합물을 추출 정제하는 방법Method for Extracting and Purifying Flavonoid Compounds from Ginkgo Leaves

제 1 도는 은행잎에서 플라보노이드 화합물을 추출정제하는 방법을 도식화한 것이다.1 is a schematic diagram of a method for extracting and purifying flavonoid compounds from ginkgo biloba leaves.

본 발명은 은행잎에서 순환기질환 개선 및 치료제인 플라보노이드를 선택적으로 추출 정제하는 방법에 관한 것으로, 특히 선택적인 새로운 추출시약을 이용하여 공정이 간단, 편리하고 경제적으로 고농도의 플라보노이드를 추출 정제하는 진보된 방법에 관한 것이다.The present invention relates to a method for selectively extracting and purifying flavonoids, which is an agent for improving and treating circulatory diseases in ginkgo biloba, and in particular, an advanced method for extracting and purifying flavonoids with high concentrations, which is simple, convenient and economical, using a new selective reagent It is about.

본 발명의 특징을 간단히 기술하면, 디옥산 수용액을 추출용매로 하여 클로로필 농도를 조절하면서 생산과정의 용이성, 안정성을 가지며 높은 수율로 고순도의 플라보노이드를 얻는데 특징이 있다. 본 발명에서는 5-30% 디옥산 수용액이 아조트로피 화합물을 이루어 클로로필 추출을 극소화하고 플라보노이드의 선택적 추출함량을 증가시킨다. 또 디옥산 수용액을 사용함으로써 끓는점을 낮게 하여 증발 농축 온도를 낮추었으며 추출, 불리하는데 소요되는 제조경비를 절감시켰고, 공정이 용이하고 간단하여 생물학적 약리효과가 높은 생리활성물질을 쉽게 얻을 수 있다.Briefly, the characteristics of the present invention are characterized by obtaining a high purity flavonoid with high yield with ease and stability of the production process while controlling the concentration of chlorophyll using dioxane aqueous solution as an extraction solvent. In the present invention, 5-30% aqueous dioxane solution forms an azotropic compound to minimize chlorophyll extraction and increase the selective extraction content of flavonoids. In addition, by using a dioxane aqueous solution, the boiling point is lowered to lower the evaporation concentration temperature, the manufacturing cost required for extraction and disadvantages is reduced, and the process is easy and simple, so that a biologically active substance having high biological pharmacological effect can be easily obtained.

은행나무는 2억년 이상 빙하시대 및 지각변동 등 기후 및 지질상의 조건변화에도 살아남아 있는 나무로서 "살아있는 화석" 이라는 이름으로 불리워지고 있고, 은행잎 몇몇 성분들이 박테리아, 세균, 병충, 곰팡이, 조류, 곤충 등에 대한 저항성이 있는 물질을 가지고 있다고 보고되었다(T. Major Randolph, Science, 1967, 157, 1270.). 수세기에 걸쳐 은행잎의 치료작용이 알려져 왔으나 현대의 약리학적 측면에서 규명된 것은 매우 취근의 일이며, 은행잎에는 3가지 계열의 플라보노이드가 존재하는데 즉, 아피제닌(Apigenine) 골격을 이루는 디메릭 플라보노이드(Dimeric Flavonoids)인 퀘세틴 글리코사이드(Quercetin Glycoside), 캄프페놀 글리코사이드(Kaempferol Glycoside), 또 올리고메릭 프로시아니딘(Oligomeric Procyanidin)과 폴리메릭 프로시아니딘(Polymeric Procyanidin)으로 분류한다. 은행잎의 약리효과 관심대상인 추출물질의 주용성분 형태는 디글리세라이드(Diglyceride)로서, 그루코오즈(Glucose)의 C6위치에 쿠마린산(Coumaric Acid)과 에스테르화할 수 있는 것으로 추출물질중 퀘세틴 글리코람노사이드 쿠마릭에스터(Quercetin-3-O-α-(6"'-coumaroyl-glucosyl-β-1.4-Rhamnoside))는 은행잎에서만 주로 나타나며 특히, 캄프페놀 글리코람노사이드 쿠마릭 에스터는 약물작용에 필수적인 것으로 보고되어 있다(P. Braquet, C. Roumestand, B. Peryly, "Plant Flavonoids in Biology and Medicine" Strasburg, France, 1987). 또 다페놀성물질과 다르게 은행잎에는 특이할 만한 중요한 성분으로 징코라이드(Ginkgolide)와 빌로바라이드(Bilobalide)계열의 디테르펜(Diterpene)과 세스퀴테르펜(Sesquiterpene)을 포함하고 있는데 이것은 오늘날 알러지성 질환 및 혈액 유동학적 면에서 치료에 매우 유망한 것으로 여겨지고 있다. 이들은 은행잎에 0.01% 미만이 포함되어 있기 때문에 오랫동안 연구하여 합성하기에 이르렀으나(Edwin B. Villbauer and Robert C. Anderson, J. Org. Chem., 1987, 52, 1186.) 불행하게도 이 제조방법은 생산규모로 실행하기에 거의 불가능하며, 현재는 약리 및 임상시험을 위해 이것들을 자연물로부터 얻는 것이 유일한 방법이다.Ginkgo biloba is a tree that survives changes in climatic and geological conditions such as ice age and tectonic change for more than 200 million years. It is called "living fossil." It has been reported to have a substance resistant to (T. Major Randolph, Science, 1967, 157, 1270.). Although the therapeutic action of ginkgo biloba has been known for centuries, it is very common to find the modern pharmacological aspect, and there are three types of flavonoids in ginkgo biloba, namely dimeric flavonoids that form the apigenine skeleton. Quercetin Glycoside, Flavonoids, Campphenol Glycoside, Oligomeric Procyanidin and Polymeric Procyanidin. Pharmacological effect of ginkgo biloba The main ingredient of the extract quality of interest is diglyceride, which can be esterified with coumarin acid at the C 6 position of Glucose. Quercetin glycolamno in the extract Side-coumaric esters (Quercetin-3-O-α- (6 "'-coumaroyl-glucosyl-β-1.4-Rhamnoside) are found only in ginkgo biloba, especially camphor phenol glycoramnoside coumaric esters (P. Braquet, C. Roumestand, B. Peryly, "Plant Flavonoids in Biology and Medicine" Strasburg, France, 1987) .In addition to polyphenols, Ginkgolide is an important ingredient that is unique to ginkgo biloba. ) And bilobalide-based diterpenes and sesquiterpenes, which are very promising for treatment in allergic diseases and hemodynamics today. They have long been studied and synthesized because they contained less than 0.01% in ginkgo biloba (Edwin B. Villbauer and Robert C. Anderson, J. Org. Chem., 1987, 52, 1186). This manufacturing method is nearly impossible to implement on a production scale, and at present it is the only way to obtain these from natural products for pharmacological and clinical trials.

은행잎에서 혈관조절 유효성분을 추출하는 것은, 활발한 연구 활동에 의해 여러 계열의 주성분을 확인하고 또, 그 성분들이 일정하다는 사실이 알려진 후 실현가능하게 되었다. 즉, 은행잎으로부터 유효성분 물질을 얻기 위해서는 식물의 경작방법, 수확시기, 건조방법, 추출과정에 이르기까지 특별한 기술이 요구된다. 은행잎에서 치료에 이용되는 고농도, 고품질의 혈관조절 유효성분을 얻기 위한 수확시기로는 방향성 수지기를 갖는 시기 즉, 은행잎이 완전히 초록색으로 된 후가 좋고, 건조방법으로는 가능한 한 빨리 통풍이 잘되는 곳에서 저온으로 건조시키는 것이 좋다. 일단 건조된 은행잎은 장기간 두어도 성분연구에 지장이 없고, 실제로 플라보노이드, 알칼로이드, 테르페노이드 같은 식물성분은 건조 후 수년이 지나도 성분변화가 없다고 전해진다.Extraction of the vasoregulatory active ingredient from ginkgo biloba was realized after active research activities identified the main components of various classes and the fact that they were constant. That is, to obtain the active ingredient material from the ginkgo biloba, special techniques are required from the tillage method, harvest time, drying method and extraction process of the plant. Harvesting time to obtain high-density, high-quality vascular control active ingredients used in the treatment of ginkgo biloba is to have aromatic resin group, that is, after the ginkgo biloba is completely green, and it is well ventilated as soon as possible by the drying method. It is good to dry at low temperature. Once dried, ginkgo biloba leaves long-term studies unaffected, and in fact, plant components such as flavonoids, alkaloids, and terpenoids are said to have no component changes even after years of drying.

약물학적, 임상병리학적 면에서 동맥순환, 모세혈관순환, 정맥순환 및 세포의 왕성한 대사 활성화, 미세순환성 혈전발생의 위험율 저하에 대한 은행잎의 약리효과 시험자료가 보고되어 있다(H. Peter, J. Fisel, W. Wiesser, Arznei Forsch, 1966, 16, 719와 G. Lagrue ; J. Baill et., A. Behar, Sem. Hop. Paris, 1978, 54, 214.). 또한 후혈전성 질환에 대한 치료효과를 연구할 목적으로 실시한 임상 및 약리시험에서 혈압 강하작용 및 모세혈관의 말초혈관 이완작용이 안정되었고(H. Trounier, Arzneim. Forsch, 1968, 18, 551.) 임상적 약리효과로서는 노인성 치매 및 Alzheimerqud, 뇌혈관 또는 외상성 상해, 노쇠에 의한 정신 행동성 질환, 말초혈관 질환, 허혈성 소인으로 추측되는 귀질환, 허혈성 망막결손 등 조화에 따른 뇌혈관 질환 치료에 대한 유효성 평가가 시행되어졌다(J. Taillandier, A. Ammar ; J. P. Rabourdin ; J. Pichon ; S. Niddan ; H. Pierart, Presse Med., 1986, 15, 1583.).In pharmacological and clinical pathology, pharmacological effects of ginkgo biloba leaf have been reported for arterial circulation, capillary circulation, venous circulation and vigorous metabolic activation of cells, and lower risk of microcirculating thrombus (H. Peter, J.). Fisel, W. Wiesser, Arznei Forsch, 1966, 16, 719 and G. Lagrue; J. Baill et., A. Behar, Sem. Hop. Paris, 1978, 54, 214. In addition, in the clinical and pharmacological studies conducted to study the therapeutic effect on post-thrombotic disease, blood pressure lowering and capillary peripheral vascular relaxation were stabilized (H. Trounier, Arzneim. Forsch, 1968, 18, 551.) The clinical pharmacological effects are effective for the treatment of cerebral vascular disease according to the condition such as senile dementia and Alzheimerqud, cerebrovascular or traumatic injury, psychiatric behavioral disease caused by senescence, peripheral vascular disease, ear disease suspected of ischemic predisposition, Assessments were made (J. Taillandier, A. Ammar; JP Rabourdin; J. Pichon; S. Niddan; H. Pierart, Presse Med., 1986, 15, 1583.).

이와 같이 은행잎의 생물학적 약리효과가 매우 크므로(L. Karcher, P. Zagemann, J. Krieglstein, Naunyn-Schmiederber's Arch. Pharmcol, 1980, 327, 31.) 이에 따른 추출, 분리 정제하는 방법도 다양하다. 은행잎에서 플라보노이드를 추출, 정제하는 기존방법중 하나가 국내특허 제 81-333 호에 공개되었다. 이 방법에서는 20-50% 저지방족 케톤 또는 저지방족 알코올 수용액을 이용하여 40-100℃에서 2-6시간 추출 후, 물과 혼합되지 않는 유기용매(CHCl3, CCl4)로 지방을 제거한 후 수용액층을 흡착제(Celite, Al2O3, CaCO3, Sucrose)를 통하여 증발농축하고 에탄올에 녹인 다음 납화합물을 첨가하여 침전시키고 유기용매층을 분리하여 감압농축시키고 다시 에탄올에 녹여 1일간 방치 후 여과하여 여과액을 감압농축하여 플라보노이드를 얻었으나, 이 방법은 공정이 대단히 복잡한 단점이 있다. 또 국내특허 제 86-651 호는 은행잎을 초음파 추출기를 이용하여(주파수 20-50KHz)추출 후 유기용매(클로로포름, 에틸아세테이트, 에테르, 벤젠, 톨루엔 등)를 이용하여 지방을 제거하고, 수용액층을 부틸알코올로 전이시키고 활성탄과 무기염을 이용하여 침강시킨 후 유효성분을 얻었으나 수율이 0.6-3.5%이므로 효율성이 낮은 단점이 있다. 또 국내특허 제 90-5318 호, 제 90-5319 호는 은행잎을 알칼리 수용액(NH4OH, Ca(OH)2등)에서 20-50℃에서 3-5시간 추출하고 여액을 산처리하여 pH 2-5로 조절한 다음 수용액층은 저급알코올, 에틸아세테이트, 저급케톤류를 이용하여 추출하고 이것을 알코올류에 녹이고 알칼리 처리하여 pH 6-8 로 조절한 다음 각각 12%, 2.5-9%의 수율로 유효활성물질을 얻었으나 그 과정이 복잡하다는 단점이 있다. 최근 공지된 국내특허 제 91- 2391 호는 은행잎 수용액에 효소(마세로신, 셀룰라제 C 및 셀룰라제 NC, 마세로신과 셀룰라제의 혼합물)를 첨가하여 일정온도에서 교반, 추출하여 원심분리 후 청정액을 얻어 이 액을 수지컬럼(암버라이트수지 XAD-2)을 통과시킨 다음 메탄올로 용풀시켜 순수한 플라보노이드를 얻었으나 공정이 복잡하고 수율이 1.0-2.0%로 낮아 생산화하기에는 어려움이 있다.As such, the biological pharmacological effects of ginkgo biloba leaves are very large (L. Karcher, P. Zagemann, J. Krieglstein, Naunyn-Schmiederber's Arch. Pharmcol, 1980, 327, 31.). One of the existing methods for extracting and purifying flavonoids from ginkgo leaves has been disclosed in Korean Patent No. 81-333. In this method, after extraction for 2-6 hours at 40-100 ° C. using 20-50% low aliphatic ketone or low aliphatic alcohol aqueous solution, the fat is removed with an organic solvent (CHCl 3 , CCl 4 ) which is not mixed with water. The layer was evaporated and concentrated through an adsorbent (Celite, Al 2 O 3 , CaCO 3 , Sucrose), dissolved in ethanol, precipitated by the addition of lead compound, the organic solvent layer was separated and concentrated under reduced pressure, dissolved in ethanol, and left for 1 day before filtration. The filtrate was concentrated under reduced pressure to obtain flavonoids, but this method has a disadvantage in that the process is very complicated. In addition, Korean Patent No. 86-651 discloses extracting ginkgo biloba leaves using an ultrasonic extractor (frequency 20-50KHz), and then removes fat using an organic solvent (chloroform, ethyl acetate, ether, benzene, toluene, etc.) After transferring to butyl alcohol and sedimentation using activated carbon and inorganic salts to obtain an active ingredient, but the yield is 0.6-3.5% has a disadvantage of low efficiency. In addition, Korean Patent Nos. 90-5318 and 90-5319 extract ginkgo biloba leaves in aqueous alkali solution (NH 4 OH, Ca (OH) 2, etc.) at 20-50 ° C. for 3-5 hours and acid treatment of the filtrate to pH 2 After adjusting to -5, the aqueous layer was extracted with lower alcohol, ethyl acetate, lower ketones, dissolved in alcohols and treated with alkali to adjust pH to 6-8, and then effective at yields of 12% and 2.5-9%, respectively. The active material is obtained but the process is complicated. Recently known Korean Patent No. 91-2391 discloses an enzyme (maserosin, cellulase C and cellulase NC, a mixture of maserosine and cellulase) in an aqueous solution of ginkgo biloba, followed by stirring and extraction at a predetermined temperature, followed by Semen was obtained and the solution was passed through a resin column (Amberlite resin XAD-2) and then molten with methanol to obtain pure flavonoids. However, the process is complicated and the yield is low at 1.0-2.0%, making it difficult to produce.

본 발명의 발명자들은 선행기술의 문제점을 해결하기 위해 연구한 결과 선택적인 새로운 추출시약을 이용하여 공정이 간단하고 편리하며 경제적으로 고농도의 플라보노이드를 추출정제하는 방법을 발명하게 되었다.The inventors of the present invention have researched to solve the problems of the prior art, and have thus invented a method for extracting and purifying flavonoids having a high concentration in a simple, convenient and economical manner by using an optional new extraction reagent.

본 발명에서의 디옥산 수용액이라는 것은 디옥산+물, 디옥산+알코올(메틸알코올, 에틸알코올, 이소프로필알코올 등) 또는 케톤류(아세톤, 메틸에틸케톤)+물을 함유한 혼합유기용매로 알코올류 및 케톤류는 전체 20% 미만을 함유하는 혼합유기용매를 총칭한다.Dioxane aqueous solution in the present invention is a mixed organic solvent containing dioxane + water, dioxane + alcohol (methyl alcohol, ethyl alcohol, isopropyl alcohol, etc.) or ketones (acetone, methyl ethyl ketone) + water. And ketones collectively refer to mixed organic solvents containing less than 20% of the total.

본 발명을 상세히 설명하면 다음과 같다. 본 발명은 은행잎으로부터 혈관조절 유효성분을 추출, 정제함에 있어 은행잎을 10-20℃에서 통풍이 잘되는 곳에서 건조, 분쇄(10-30mesh)하여 20-50℃에서 5-30% 디옥산 수용액을 이용하여 환류냉각하면서 추출하였고, 또한 용해도를 증가시키기 위해서 수산화나트륨, 수산화칼륨, 수산화칼슘, 인산나트륨, 탄산나트륨 등을 이용하여 pH 8-13으로 조절하였다. 플라보노이드의 배당체인 경우는 물에 비교적 잘 녹으나, 유리형은 난용인 것이 많고, 플라보노이드의 배당체의 경우 강알칼리에서는 3위치에 수산기가 있는 물질이 추출이 잘되고 약 알칼리에서는 7위치에 수산기가 있는 물질이 추출이 잘되므로 수율과 순도를 각각 증가시킬 수 있다. 이 방법으로 1-5시간 추출한 후 여과하여 여과액을 감압(60mmHg 이하)농축시키고, 클로로필 및 지방산을 제거하기 위하여 물에 불용성인 유기용매(에틸에테르, 석유에테르 등)로 추출하고, 수용액층을 다시 유기용매(부틸알코올, 아밀알코올, 메틸에틸케톤, 에틸아세테이트 또는 그 혼합물)로 추출, 분배시킨다. 유기용매층을 감압(60mmHg 이하 ; 이하 감압이라 함은 600mmHg 이하를 말한다)건조시켜 고농도의 플라보노이드 화합물을 얻는다. 추출시 사용된 디옥산 잔류량을 확인하기 위해 가스크로마토그래피를 이용하여 디오산 잔류량이 없음을 확인하고 이렇게 얻은 건조물을 에틸알코올에 용해시켜 여과 후 감압건조(500mmHg, 40℃)하여 순수 플라보노이드 화합물을 얻는다.The present invention is described in detail as follows. In the present invention, in extracting and purifying the vascular control active ingredient from the ginkgo biloba, the ginkgo biloba is dried and pulverized in a well-ventilated place at 10-20 ° C (10-30mesh) to use an aqueous solution of 5-30% dioxane at 20-50 ° C. The mixture was extracted with reflux cooling, and adjusted to pH 8-13 using sodium hydroxide, potassium hydroxide, calcium hydroxide, sodium phosphate, sodium carbonate and the like to increase solubility. Flavonoid glycosides are relatively well soluble in water, but glassy forms are poorly soluble, and flavonoid glycosides have a good extraction of 3 hydroxyl groups in strong alkalis and 7 hydroxyl positions in weak alkalis. Good extraction can increase yield and purity, respectively. After extracting by this method for 1-5 hours, the filtrate was concentrated under reduced pressure (60 mmHg or less), extracted with an organic solvent (ethyl ether, petroleum ether, etc.) insoluble in water to remove chlorophyll and fatty acids, and the aqueous layer was Then, the mixture is extracted and partitioned with an organic solvent (butyl alcohol, amyl alcohol, methyl ethyl ketone, ethyl acetate or a mixture thereof). The organic solvent layer is dried under reduced pressure (60 mmHg or less; hereafter referred to as 600 mmHg or less) to obtain a high concentration of flavonoid compound. In order to confirm the residual amount of dioxane used during extraction, it was confirmed that there was no residual amount of dioxane using gas chromatography, and the dried product was dissolved in ethyl alcohol, filtered, and dried under reduced pressure (500 mmHg, 40 ° C) to obtain a pure flavonoid compound. .

상기 방법에서 얻어진 혈관조절 유효활성물질은 황갈색 색소분말로서 플라보노이드 배당체중 퀘세틴 글리코사이드, 캄프페놀 글리코사이드, 이소람네틴 글리코사이드(Isorhamnetin Glycoside)를 함유하고 있으며, 배당체의 경우 표 1에 수록된 박층 크로마토그래피의 조건에 의해서 정성분석을 한 결과 퀘세틴 글리코사이드, 이소람네틴 글리코사이드, 캄프페놀 글리코사이드 Rf값이 각각 0.39, 0.53, 0.58를 나타내었다. 각각을 정량분석하기 위하여 산가수분해시킨 후 표 2에 수록된 조건에 따라 고성능 액체크로마토그래피로 분석한 결과 퀘세틴, 캄프페놀, 이소람네틴의 R.T.(Retention Time, minutes)는 컬럼 효율에 따라 다소 차이는 있으나 각각 15.44, 25.34, 28.54를 나타내었다.The vasoregulatory active substance obtained in the above method is a tan pigment, which contains quercetin glycoside, camphor phenol glycoside, and isorhamnetin glycoside in flavonoid glycosides, and the thin layer chromatography of glycosides listed in Table 1 As a result of qualitative analysis under the conditions of the graph, the quercetin glycoside, isoramnetine glycoside, and camphor phenol glycoside Rf values were 0.39, 0.53, and 0.58, respectively. Acid hydrolysis to quantitatively analyze each of them, followed by high performance liquid chromatography according to the conditions listed in Table 2, showed that the RT (Retention Time, minutes) of quercetin, camphor phenol and isoramnetine differed slightly depending on the column efficiency. However, they were 15.44, 25.34 and 28.54, respectively.

[표 1]TABLE 1

박층크로마토그래피의 분석 조건Analysis conditions of thin layer chromatography

[표 2]TABLE 2

고성능액체크로마토그래피의 분석 조건Analysis Conditions of High Performance Liquid Chromatography

[실시예 1]Example 1

은행잎 건조분말 100g에 30% 디옥산수용액 1L를 넣고 35±5℃에서 환류 냉각시키면서 5시간 동안 추출한 후 여과하여 여액을 감압(400±50mmHg)농축시켰다. 농축액에 1% 암모늄 수용액을 500ml 넣고 교반, 여과하여 여액을 아밀알코올로 추출 후 유기용매층을 감압건조(500±50mmHg, 30±5℃)시켜 건조물을 얻었다. 건조물을 다시 에탄올로 용해하여 용해되지 않는 부분은 여과하고, 여액을 감압건조(300±5mmHg, 40±5℃)시켜 11.5g의 분말을 얻었다. 이것의 유효성분인 플라보노이드의 정성분석은 표 1의 조건에 준하여 시험하였으며, 정량분석은 표 2의 조건에 준하여 각각 순도를 분석한 결과 총 플라보노이드로서 24% 이상이었다.1 g of 30% dioxane aqueous solution was added to 100 g of dry powder of ginkgo biloba and extracted for 5 hours while refluxing at 35 ± 5 ° C., and the filtrate was concentrated under reduced pressure (400 ± 50 mmHg). 500 ml of 1% aqueous ammonium solution was added to the concentrated solution, followed by stirring and filtration. The filtrate was extracted with amyl alcohol, and the organic solvent layer was dried under reduced pressure (500 ± 50 mmHg, 30 ± 5 ° C.) to obtain a dried product. The dried product was again dissolved in ethanol, and the insoluble part was filtered, and the filtrate was dried under reduced pressure (300 ± 5 mmHg, 40 ± 5 ° C.) to obtain 11.5 g of powder. Qualitative analysis of flavonoids, an active ingredient thereof, was tested according to the conditions of Table 1, and quantitative analysis was more than 24% as a total flavonoid as a result of analyzing the purity according to the conditions of Table 2.

[실시예 2]Example 2

은행잎 건조분말 100g에 디옥산 : 메탄올 : 물=1 : 1 : 8 혼합용액 500ml를 넣고 45±5℃에서 3시간 동안 추출한 후 여과하는 것을 2회 반복하였다. 여액을 모아, 여액의 30%까지 농축시키고 농축액에 포화염화나트륨 수용액을 100ml 넣고 교반한 후 여과하였다. 여액을 부틸알코올 : 아밀알코올(4 : 1)로 추출하여 유기용매층을 감압건조(400±50mmHg, 45±5℃)시켜 유효활성분말 10.7g을 얻었다. 표 1, 표 2의 분석방법에 따라 정성 및 정량분석한 결과 순도는 총 플라보노이드로서 24% 이상이었다.To 100 g of ginkgo biloba dry powder was added 500 ml of dioxane: methanol: water = 1: 1: 1 mixed solution, extracted at 45 ± 5 ° C. for 3 hours, and then filtered twice. The filtrate was collected, concentrated to 30% of the filtrate, and 100 ml of saturated sodium chloride aqueous solution was added to the concentrated solution, followed by stirring and filtering. The filtrate was extracted with butyl alcohol: amyl alcohol (4: 1), and the organic solvent layer was dried under reduced pressure (400 ± 50 mmHg, 45 ± 5 ° C.) to obtain 10.7 g of an active powder. According to the analytical method of Table 1 and Table 2, the purity was more than 24% as a total flavonoid.

[실시예 3]Example 3

은행잎 건조분말 100g을 25% 디옥산 수용액 500ml로 40±5℃에서 3시간 동안 추출한 후 여과하는 것을 2회 반복하였다. 여액을 모아 감압(400±50mmHg)농축시키고, 농축액을 에틸에테르로 추출하고 상등액을 다시 부틸알코올 200ml로 2회 추출하여 유기용매층을 감압건조시켜(250±50mmHg, 45±3℃) 혈관조절 유효활성물질인 플라보노이드를 7.9g을 얻었다. 표 1, 표 2 분석방법에 따라 정성 및 정량분석한 결과 순도는 총 플라보노이드로서 30% 이상이었다.100 g of dried ginkgo biloba powder was extracted with 500 ml of 25% aqueous dioxane solution at 40 ± 5 ° C. for 3 hours, and then filtered twice. Collect the filtrate and concentrate under reduced pressure (400 ± 50mmHg), extract the concentrated solution with ethyl ether, and extract the supernatant twice with 200ml of butyl alcohol, and dry the organic solvent layer under reduced pressure (250 ± 50mmHg, 45 ± 3 ℃). 7.9 g of an active substance flavonoid was obtained. The qualitative and quantitative analysis of Table 1 and Table 2 showed that the purity was over 30% as total flavonoids.

[실시예 4]Example 4

은행잎 건조분말 100g에 10% 디오산 수용액 500ml을 넣고 1N 수산화나트륨으로 pH 12±0.5로 조절하여 용해도를 증가시켜 40±5℃에서 3시간씩 2회 추출하고 여액을 모아 감압(350±50mmHg)농축시켰다. 농축액을 부틸알코올 : 아밀알코올(3 : 1)로 주출하여 유기용매층을 감압농축(350±50mmHg, 40±3℃)시켜 10.4g의 유효활성물질을 얻었다. 표 1, 표 2의 분석조건에 따라 정성 및 정량분석한 결과 순도는 총 플라보노이드로서 24% 이상을 나타내었다.Add 100 ml of 10% dioxane aqueous solution to 100 g of dried powder of Ginkgo biloba, adjust the pH to 12 ± 0.5 with 1N sodium hydroxide to increase the solubility, extract 2 times at 40 ± 5 ℃ for 3 hours, and collect the filtrate and concentrate under reduced pressure (350 ± 50mmHg). I was. The concentrated solution was extracted with butyl alcohol: amyl alcohol (3: 1), and the organic solvent layer was concentrated under reduced pressure (350 ± 50 mmHg, 40 ± 3 ° C) to obtain 10.4 g of an active substance. According to the analysis conditions of Table 1 and Table 2, the qualitative and quantitative analysis showed that the purity was more than 24% as total flavonoids.

[실시예 5]Example 5

은행잎 건조분말 100g을 디옥산 : 아세톤 : 증류수=1 : 1 :5 혼합용액으로 40±5℃에서 2시간씩 2회 추출여과하였다. 여액은 석유에테르로 지방을 제거하고 수용액층은 다시 부틸알코올로 추출하여 유기용매층을 감압건조(350±50mmHg, 40±3℃)시켜 7.3g의 혈관조절 유효활성물질을 얻었다. 표 1, 표 2 분석조건에 따라 정성 및 정량분석한 결과 총 플라보노이드 순도는 30% 이상이었다.100 g of dried ginkgo biloba powder was extracted and filtered twice at 40 ± 5 ° C. for 2 hours with dioxane: acetone: distilled water = 1: 1: 1 mixture solution. The filtrate was removed fat with petroleum ether and the aqueous layer was extracted again with butyl alcohol, and the organic solvent layer was dried under reduced pressure (350 ± 50 mmHg, 40 ± 3 ° C.) to obtain 7.3 g of a blood vessel regulating active substance. Qualitative and quantitative analysis of Table 1 and Table 2 showed that the total flavonoid purity was more than 30%.

[실시예 6]Example 6

은행잎 건조분말 100g에 20% 디옥산 수용액 500ml를 넣고 1N 수산화칼륨으로 pH 11±0.5호 조절한 후 50±5℃에서 4시간씩 2회 추출하고 여액을 모아 50%로 감압농축(300±50mmHg)하였다. 부틸알코올 : 메틸에틸케톤(1 : 4)으로 분배시켜 유기용매층을 감압건조(250±50mmHg, 35±5℃)하여 플라보노이드 화합물 10.5g을 얻었다. 이 화합물은 표 1, 표 2에 따라 분석한 결과 총 플라보노이드의 순도가 24% 이상이었다.Add 100 ml of 20% dioxane aqueous solution to 100 g of dry powder of ginkgo biloba, adjust pH 11 ± 0.5 with 1N potassium hydroxide, extract twice at 50 ± 5 ℃ for 4 hours, collect filtrate and concentrate under reduced pressure to 50% (300 ± 50mmHg). It was. Butyl alcohol: It was partitioned into methyl ethyl ketone (1: 4), and the organic solvent layer was dried under reduced pressure (250 ± 50 mmHg, 35 ± 5 ° C) to obtain 10.5 g of a flavonoid compound. The compound was analyzed according to Table 1 and Table 2 and the purity of the total flavonoids was 24% or more.

[실시예 7]Example 7

은행잎 건조분말 100g에 10% 디옥산 수용액 500ml를 넣고 1N 수산화나트륨으로 pH 11±0.5로 조절한 후 45±5℃에서 환류냉각하면서 4시간씩 2회 추출, 여과한 후 여액을 모아 감압농축(250±50mmHg)하였다. 석유에테르로 지방을 추출 제거하고 수용액층을 부틸알코올 : 에틸아세테이트(1 : 4)로 추출분배시켜 유기용매층을 감압건조(250±50mmHg, 35±5℃)하여 유효활성물질 7.1g을 얻었다. 이 물질을 표 1, 표 2의 분석조건에 따라 분석한 결과 총 플라보노이드의 순도가 30% 이상이었다.500 g of 10% dioxane aqueous solution was added to 100 g of dried powder of ginkgo biloba, adjusted to pH 11 ± 0.5 with 1N sodium hydroxide, extracted twice with 4 hours while refluxing at 45 ± 5 ℃, filtered and concentrated under reduced pressure (250). ± 50 mmHg). Fat was extracted with petroleum ether, and the aqueous layer was extracted and distributed with butyl alcohol: ethyl acetate (1: 4), and the organic solvent layer was dried under reduced pressure (250 ± 50 mmHg, 35 ± 5 ° C.) to obtain 7.1 g of an active substance. This material was analyzed according to the analysis conditions of Table 1 and Table 2, and the total flavonoid purity was 30% or more.

[실시예 8]Example 8

은행잎 건조분말 100g을 디옥산 : 에틸아세테이트 : 증류수(1 : 1 : 8) 혼합용액 500ml로 40±5℃에서 3시간씩 2회 추출 여과하였다. 여액을 모아 감압(250±50mmHg)농축시킨 후 1% 염화암모늄 수용액 100ml를 넣고 교반, 방치, 여과한 후 여액을 부틸알코올 : 메틸에틸케톤(1 : 5)로 추출하여 유기용매층으로 분배시키고, 유기용매층을 감압건조(250±50mmHg, 35±5℃)시켜 유효활성물질 10.1g을 얻었다. 이 활성물질은 표 1, 표 2의 분석조건에 따라 분석한 결과 총 플라보노이드의 순도가 24%이상이었다.100 g of ginkgo biloba dry powder was extracted and filtered twice with 40 ml of a mixed solution of dioxane: ethyl acetate: distilled water (1: 1: 1) at 40 ± 5 ° C. Collect the filtrate and concentrate under reduced pressure (250 ± 50mmHg), add 100ml of 1% aqueous ammonium chloride solution, stir, leave, and filter. The filtrate is extracted with butyl alcohol: methyl ethyl ketone (1: 5) and partitioned into an organic solvent layer. The organic solvent layer was dried under reduced pressure (250 ± 50 mmHg, 35 ± 5 ° C.) to obtain 10.1 g of an active substance. According to the analytical conditions of Table 1 and Table 2, this active substance was found to have a total flavonoid purity of 24% or more.

[실시예 9]Example 9

은행잎 건조분말 100g을 디옥산 : 에틸아세테이트 : 증류수(1 : 1 : 4) 혼합용액 500m로 Soxhlet 장치를 이용하여 35±5℃에서 5시간 환류냉각하면서 추출하고, 추출액을 감압(300±50mmHg)농축시켰다. 에틸에테르로 지방을 제거한 후 수용액을 부틸알코올 : 에틸아세테이트(1 : 5) 혼합용매로 분배, 전이시키고, 이 유기용매층을 감압건조(250±50mmHg, 35±5℃)시켜 플라보노이드의 화합물 7.6g을 얻었다. 표 1, 표 2의 분석조건에 따라 분석한 결과 순도가 총 플라보노이드로서 30% 이상이었다.100 g of dried ginkgo biloba powder was extracted with dioxane: ethyl acetate: distilled water (1: 1: 4) mixed solution at 500m with reflux cooling at 35 ± 5 ° C for 5 hours using a Soxhlet apparatus, and the extract was concentrated under reduced pressure (300 ± 50mmHg). I was. After removing the fat with ethyl ether, the aqueous solution was partitioned and transferred to butyl alcohol: ethyl acetate (1: 5) mixed solvent, and the organic solvent layer was dried under reduced pressure (250 ± 50 mmHg, 35 ± 5 ° C.) to give 7.6 g of a flavonoid compound. Got. According to the analysis conditions of Table 1 and Table 2, the purity was more than 30% as the total flavonoids.

[실시예 10]Example 10

은행잎 건조분말 100g을 20% 디옥산 수용액 500ml에 넣고 1N 수산화칼륨으로 pH를 11±0.5로 조절한후 40±5℃에서 2시간씩 2회추출, 여과한 다음 여액을 모아 감압농축(300±50mmHg)시키고 부틸알코올 : 메틸에틸케톤(1 : 4)의 혼합용액으로 추출분배시켰다. 분배액을 감압건조(350±50mmHg, 40±5℃)한 후 석유에테르로 다시 추출여과하여 유효활성물질 5.4g을 얻었고 이 물질은 표 1, 표 2의 분석조건에 따라 분석한 결과 총 플라보노이드로서 40% 이상을 얻었다.100 g of dried ginkgo biloba powder was added to 500 ml of 20% aqueous dioxane solution, and the pH was adjusted to 11 ± 0.5 with 1N potassium hydroxide. The extract was filtered twice at 40 ± 5 ° C for 2 hours, filtered and concentrated under reduced pressure (300 ± 50mmHg). Then, the mixture was extracted and distributed with a mixed solution of butyl alcohol: methyl ethyl ketone (1: 4). The mixture was dried under reduced pressure (350 ± 50mmHg, 40 ± 5 ℃) and filtered and extracted again with petroleum ether to obtain 5.4g of active active material. The material was analyzed under the analysis conditions in Table 1 and Table 2 as a total flavonoid. Got more than%.

[실시예 11]Example 11

은행잎 건조분말 100g을 25% 디옥산 수용액 500ml에 넣고 1N 수산화나트륨으로 pH를 12±0.5로 조절하여 40±5℃에서 2시간씩 2회 추출 여과한 후 여액을 모아 감압농축(400±50mmHg)시킨 다음 부틸알코올 : 에틸아세테이트(1 : 3)로 추출분배시켰다. 이 분배액을 감압건조(250±50mmHg, 35±5℃)시킨 분말을 에틸에테르로 다시 추출여과하여 유효활성물질 5.2g을 얻었고 이 물질은 표 1, 표 2의 분석조건에 의하여 총 플라보노이드로서 40% 이상이었다.100 g of dried ginkgo biloba powder was added to 500 ml of 25% dioxane aqueous solution, the pH was adjusted to 12 ± 0.5 with 1N sodium hydroxide, and extracted and filtered twice at 40 ± 5 ° C. for 2 hours, and the filtrates were concentrated under reduced pressure (400 ± 50 mmHg). Then extracted with butyl alcohol: ethyl acetate (1: 3). The powder was dried under reduced pressure (250 ± 50mmHg, 35 ± 5 ℃) and filtered and filtered again with ethyl ether to obtain 5.2g of the active substance, which was 40% of the total flavonoids according to the analysis conditions of Table 1 and Table 2. It was above.

[실시예 12]Example 12

은행잎 건조분말 100g을 디옥산 : 에틸아세테이트 : 증류수(1 : 1 : 5) 혼합용액 500ml에 넣어 40±5℃에서 2시간씩 2회 추출 여과하였다. 여액을 모아 감압(300±50mmHg)농축시키고 농축액을 부틸알코올 : 에틸아세테이트(1 : 4)로 추출분배시켰다. 이 액을 감압건조(300±50mmHg, 35±5℃)시켜 다시 에틸에테르로 추출 후 여과하여 유효활성물질 5.1g을 얻었고 이 활성물질은 표 1, 표 2에 따라 분석결과 총 플라보노이드로서 순도가 40% 이상이었다.100 g of dry powder of ginkgo biloba was added to 500 ml of a mixed solution of dioxane: ethyl acetate: distilled water (1: 1: 1), and extracted and filtered twice at 40 ± 5 ° C for 2 hours. The filtrates were combined and concentrated under reduced pressure (300 ± 50 mmHg), and the concentrate was extracted and distributed with butyl alcohol: ethyl acetate (1: 4). The solution was dried under reduced pressure (300 ± 50mmHg, 35 ± 5 ℃), extracted with ethyl ether, filtered and filtered to obtain 5.1g of the active substance. The active substance was purified as total flavonoids according to Table 1 and Table 2. It was over%.

Claims (3)

은행잎을 디옥산+물, 디옥산+저급알코올+물 및 디옥산+저급케톤+물로 구성되는 군에서 선택되는 pH 8∼13범위의 디옥산 수용액으로 30∼55℃에서 추출 여과한 후, 여과한 수용액층을 물에 불용성인 유기용매로 추출하고, 추출 후 얻어진 수용액층을 부틸알코올, 아밀알코올, 메틸에틸케톤 및 에틸아세테이트로 구성되는 군에서 선택되는 유기용매 또는 그 혼합물로 추출분배하고 유기용매층을 600mmHg 이하로 감압건조시키는 것을 특징으로 하는, 은행잎에서 플라보노이드 화합물을 추출정제하는 방법.The ginkgo biloba leaves were extracted and filtered at 30-55 ° C. with dioxane aqueous solution having a pH range of 8-13 selected from the group consisting of dioxane + water, dioxane + lower alcohol + water and dioxane + lower ketone + water. The aqueous layer was extracted with an organic solvent insoluble in water, and the aqueous layer obtained after extraction was extracted and distributed with an organic solvent or a mixture thereof selected from the group consisting of butyl alcohol, amyl alcohol, methyl ethyl ketone and ethyl acetate, and then an organic solvent layer. Method for extracting and purifying flavonoid compounds from ginkgo leaves, characterized in that the dried under reduced pressure to 600mmHg or less. 제 1 항에 있어서, 상기 디옥산 수용액에서 저급알코올과 저급케톤이 전체의 20% 미만인 것을 특징으로 하는 방법.The method of claim 1, wherein the lower alcohol and lower ketone in the dioxane aqueous solution is less than 20% of the total. 제 1 항에 있어서, 상기 유기용매층을 600mmHg 이하로 건조시킨 후, 추가로 에틸에테르 또는 석유에 테르로 추출하는 단계를 포함하는 것을 특징으로 하는 방법.The method of claim 1, further comprising drying the organic solvent layer to 600 mmHg or less, followed by extraction with ethyl ether or petroleum ether.
KR1019920017343A 1992-09-23 1992-09-23 Method of extraction and purification of flavonoid compounds in ginko leaves KR960004022B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019920017343A KR960004022B1 (en) 1992-09-23 1992-09-23 Method of extraction and purification of flavonoid compounds in ginko leaves

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019920017343A KR960004022B1 (en) 1992-09-23 1992-09-23 Method of extraction and purification of flavonoid compounds in ginko leaves

Publications (2)

Publication Number Publication Date
KR940006596A KR940006596A (en) 1994-04-25
KR960004022B1 true KR960004022B1 (en) 1996-03-25

Family

ID=19339993

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920017343A KR960004022B1 (en) 1992-09-23 1992-09-23 Method of extraction and purification of flavonoid compounds in ginko leaves

Country Status (1)

Country Link
KR (1) KR960004022B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006009373A1 (en) * 2004-07-22 2006-01-26 Seoul National University Industry Foundation The purified leaf extract of ginkgo biloba having neuronal cell-protecting activity, the method for preparing them and the composition comprising the same

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102038107B1 (en) 2016-12-29 2019-10-29 영진약품 주식회사 Novel flavonoid compound from Stauntonia hexaphyll leaf extract and composition for anti-inflammatory, and improvement of bone tissue generation or cartilage tissue generation
KR102126575B1 (en) 2017-11-03 2020-06-24 영진약품 주식회사 Pharmaceutical composition for anti-inflammatory, and improvement of bone tissue generation or cartilage tissue generation comprising purified fraction materials from Stauntonia hexaphylla leaves or flavonoid compounds and caffeic acid compounds separated therefrom as active ingredients
KR102241369B1 (en) 2020-02-25 2021-04-15 영진약품 주식회사 Pharmaceutical composition for anti-inflammatory, and improvement of bone tissue generation or cartilage tissue generation comprising purified fraction materials from Stauntonia hexaphylla leaves or flavonoid compounds and caffeic acid compounds separated therefrom as active ingredients

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006009373A1 (en) * 2004-07-22 2006-01-26 Seoul National University Industry Foundation The purified leaf extract of ginkgo biloba having neuronal cell-protecting activity, the method for preparing them and the composition comprising the same

Also Published As

Publication number Publication date
KR940006596A (en) 1994-04-25

Similar Documents

Publication Publication Date Title
Baron-Ruppert et al. Evidence for toxic effects of alkylphenols from Ginkgo biloba in the hen's egg test (HET)
JP2800040B2 (en) New extract of ginkgo and its manufacturing method
US4248789A (en) Process for producing catechins
EP0402925B1 (en) A method of isolating ginkgolides from the leaves of the ginkgo tree and purifying them
EP1755629A1 (en) Ginkgo biloba extract and method for producing the same
US5637302A (en) Extracts of Ginkgo biloba and their methods of preparation
AT502717A1 (en) PHARMACEUTICAL USE OF A COMPOUND
DE60207878T2 (en) SOLVENT EXTRACTION PROCESS
DE60202603T2 (en) 8- (C-BETA-D-GLUCOPYRANOSYL) -7,3 ', 4'-TRIHYDROXYFLAVONE, METHOD FOR THE ISOLATION OF PTEROCARPUS MARSUPIUM AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIABETES
KR960004022B1 (en) Method of extraction and purification of flavonoid compounds in ginko leaves
KR20010052636A (en) Extracts of Hypericum perforatum and formulations containing them
RU2514673C2 (en) Method of removing pesticides from ginkgo biloba extracts and extracts obtained using said method
KR100703242B1 (en) Extraction method of a compound from vegetable material
JPH03227985A (en) Simple production of extract with high content of flavonoid from ginkgo leaf
DE60213447T2 (en) Process for the preparation of hydroxymatairesinol or a hydroxymatairesinol complex of wood
US2425094A (en) Process for obtaining rutin from buckwheat
US6447819B2 (en) Water-soluble complex of an extract of Ginkgo biloba, process for the preparation thereof and composition comprising the same
DE2609533A1 (en) PROCESS FOR EXTRACTION OF ACTIVE SUBSTANCES, IN PARTICULAR OF HETEROSIDE EAST, COFFEE ACID, AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
SU931188A1 (en) Method of producing phenol, exhibiting antiinflammatory effect
AT400673B (en) METHOD FOR THE PRODUCTION OF MEDICAL PLANT EXTRACTS
RU2176515C1 (en) Method of preparing total polysaccharide from vegetable raw
KR900005319B1 (en) Process for purifying physiological active materials from ginko tree leaves
Sharova et al. Influence of mineral fertilizers on the accumulation of biologically active substances in Silybum marianum (L.) Gaertn. leaves in the middle urals
KR890000651B1 (en) Extraction method concentrated flavonoides from ginkgo leaf
EP0442537B1 (en) A mental disease therapeutic agent

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20090302

Year of fee payment: 14

LAPS Lapse due to unpaid annual fee